Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) FCF Margin (2019 - 2020)

Alx Oncology Holdings' FCF Margin history spans 2 years, with the latest figure at 1538.14% for Q2 2020.

  • On a quarterly basis, FCF Margin changed N/A to 1538.14% in Q2 2020 year-over-year; TTM through Mar 2021 was 6544.4%, a 620562.0% decrease, with the full-year FY2020 number at 3241.96%, down 293750.0% from a year prior.
  • FCF Margin hit 1538.14% in Q2 2020 for Alx Oncology Holdings, down from 1369.92% in the prior quarter.
  • Over the last five years, FCF Margin for ALXO hit a ceiling of 231.82% in Q4 2019 and a floor of 1538.14% in Q2 2020.